STOCKHOLM, SE / ACCESS Newswire / April 25, 2025 / iZafe Group (STO:IZAFE-B) - iZafe Group AB (publ.) presents today, April 25th, its report for the first quarter.Financial Performance in SummaryTotal ...

CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Zurich, 25th of April 2025: Xlife Sciences AG ("Xlife Sciences", ...

VANCOUVER, BC / ACCESS Newswire / April 24, 2025 / Onco-Innovations Limited (CSE:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H,WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce that its wholly owned ...

SAN DIEGO, CA / ACCESS Newswire / April 24, 2025 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) (the "Company"), a clinical-stage pharmaceutical company developing innovative solutions for severe pain ...

LEXINGTON, KENTUCKY / ACCESS Newswire / April 24, 2025 / Today, NX Development Corp ("NXDC"), a Lexington, KY based life sciences company, announced the return of the sales and marketing rights for ...

Interim Statement on the First Three Months of Financial Year 2025Cohort 7 of the clinical trial of HDP-101 in multiple myeloma safe and well toleratedCohort 8 expected to start soonClinical ...

OXB Named Among UK’s Best Employers by Financial Times in 2025Oxford, UK – OXB (LSE: OXB), a global quality and innovation-led cell and gene therapy CDMO, has been honoured with a spot on the ...

Bioxodes announces positive Phase 2a interim data for BIOX-101 in intracerebral hemorrhagic stroke patientsPrimary endpoint met, no drug-related serious adverse events Positive hematoma and edema ...

Syncona Limited Mosaic Therapeutics in-licences two clinical-stage assets from Astex Pharmaceuticals In-licensing these clinical-stage assets has significantly de-risked and accelerated Mosaic’s ...

NEW IQVIA INSTITUTE REPORT WARNS OF ACCESS DISPARITIES FOR CAR T-CELL THERAPY ACROSS EUROPE Stockley Park, UK – 23 April 2025 – A new report reveals disparities in chimeric antigen receptor (CAR) ...

Hikma reiterates full year guidance following good start to the year London, 24 April 2025 – Hikma Pharmaceuticals PLC (Hikma, Group), the multinational pharmaceutical group, today provides an update ...

A New Movement Calls for Change Women are being overlooked in the UK’s HIV response and face multiple barriers to prevention, testing, and care.In England, HIV diagnoses among women who have sex with ...